| Literature DB >> 33368193 |
Nicolas Rive Le Gouard1, Adeline Jacquinet1,2, Lyse Ruaud1, Hélène Deleersnyder1, Faustine Ageorges1, Jennifer Gallard1, Didier Lacombe3, Sylvie Odent4, Myriam Mikaty4, Sylvie Manouvrier-Hanu5, Jamal Ghoumid5, David Geneviève6, Natacha Lehman6, Nicole Philip7, Patrick Edery8, Delphine Héron9, Coralie Rastel9, Sophie Chancenotte10, Christel Thauvin-Robinet10, Laurence Faivre10, Laurence Perrin1, Alain Verloes1.
Abstract
Smith-Magenis syndrome (SMS), characterized by dysmorphic features, neurodevelopmental disorder, and sleep disturbance, is due to an interstitial deletion of chromosome 17p11.2 (90%) or to point mutations in the RAI1 gene. In this retrospective cohort, we studied the clinical, cognitive, and behavioral profile of 47 European patients with SMS caused by a 17p11.2 deletion. We update the clinical and neurobehavioral profile of SMS. Intrauterine growth was normal in most patients. Prenatal anomalies were reported in 15%. 60% of our patients older than 10 years were overweight. Prevalence of heart defects (6.5% tetralogy of Fallot, 6.5% pulmonary stenosis), ophthalmological problems (89%), scoliosis (43%), or deafness (32%) were consistent with previous reports. Epilepsy was uncommon (2%). We identified a high prevalence of obstipation (45%). All patients had learning difficulties and developmental delay, but ID range was wide and 10% of patients had IQ in the normal range. Behavioral problems included temper tantrums and other difficult behaviors (84%) and night-time awakenings (86%). Optimal care of SMS children is multidisciplinary and requires important parental involvement. In our series, half of patients were able to follow adapted schooling, but 70% of parents had to adapt their working time, illustrating the medical, social, educative, and familial impact of having a child with SMS.Entities:
Keywords: 17p11.2; Smith-Magenis; clinical characteristics; neurodevelopmental disorder; obstipation; social impact
Mesh:
Year: 2021 PMID: 33368193 DOI: 10.1111/cge.13906
Source DB: PubMed Journal: Clin Genet ISSN: 0009-9163 Impact factor: 4.438